Moomoo AI 已提取核心信息
Marc Feldmann, associated with 180 Life Sciences Corp. [ATNF], was granted 135,377 shares of common stock on December 28, 2023. The transaction, which is currently in progress, was conducted at no cost to Feldmann. Following this grant, Feldmann's direct holdings in the company increased to a total of 250,874 shares of common stock. The nature of the transaction indicates a direct acquisition of shares, reflecting a potential increase in Feldmann's vested interest in the company.
Marc Feldmann, associated with 180 Life Sciences Corp. [ATNF], was granted 135,377 shares of common stock on December 28, 2023. The transaction, which is currently in progress, was conducted at no cost to Feldmann. Following this grant, Feldmann's direct holdings in the company increased to a total of 250,874 shares of common stock. The nature of the transaction indicates a direct acquisition of shares, reflecting a potential increase in Feldmann's vested interest in the company.
与180生命科学公司 [ATNF] 相关的马克·费尔德曼于2023年12月28日获得135,377股普通股。该交易目前正在进行中，是费尔德曼免费进行的。在这笔赠款之后，费尔德曼在该公司的直接持股量增加到总共250,874股普通股。该交易的性质表明直接收购了股份，这反映了费尔德曼在公司的既得权益的潜在增加。
与180生命科学公司 [ATNF] 相关的马克·费尔德曼于2023年12月28日获得135,377股普通股。该交易目前正在进行中，是费尔德曼免费进行的。在这笔赠款之后，费尔德曼在该公司的直接持股量增加到总共250,874股普通股。该交易的性质表明直接收购了股份，这反映了费尔德曼在公司的既得权益的潜在增加。
有用
没用